6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Court Orders Convening Scheme Meeting
Just now	Maiden Drilling Commences at Reynolds & Reitenbach Lake
Just now	NWQ Big One Copper Site Assessment and Tenement Expansion
Just now	Walgoolan Project Update Grant of Tenement
37m ago	Credissential Announces Shares Consolidation

About

Esperion Therapeutics Inc (NASDAQ:ESPR) — investor relations, events, news, and company updates on 6ix.

Latest News

Esperion to Report First Quarter 2026 Financial Results on May 7

Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

Esperion to Participate in 25th Annual Needham Virtual Healthcare Conference

Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026

Financials

Revenue

$403.14 M

Market Cap

$670.28 M

EPS

-0.11

Community Chat

Ask AI